Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04117919Phase 2Unknown
Phase 2, randomised, single-blind trial of paper mulberry leaf in plaque psoriasis (2 arms), sponsored by China Medical University Hospital. Primary endpoint: Major or Partial Clinical Response defined by Psoriasis Area Severity Index at 8 weeks. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04117919.